Ann: Positive clinical trial results for Progenza, page-13

"Progenza includes secretions from MSCs that improves viability and functionality of the cells during the freezing and thawing process.  Regeneus has shown that a combination of cells and secretions has a more powerful therapeutic effect than cells alone."

RGS's secretions technology may turn out to be a unique product platform in regenerative medicine, and probably the key reason why AGC did a JV deal with Regeneus.

REG's secretions technology came in 2015 via a collaboration with Macquarie University.

http://www.mq.edu.au/newsroom/2015/...n-the-door-to-next-generation-cell-therapies/